Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: August 30, 2005
Last updated: November 21, 2012
Last verified: November 2012